Ncardia presents a cutting-edge approach using iPSC-derived 3D cardiac microtissues and Ncyte® Heart in a BoxTM to evaluate cardiovascular drug candidates in a high-throughput screening format. This poster showcases how these approaches provide a cost-effective and scalable solution for disease modeling and drug screening.
"Advancing Cardiovascular Drug Discovery With iPSC-Derived 3D Cardiac Microtissues in High-Throughput Screening"
Presenter: Benoit Samson-Couterie
Poster Session 1: Wednesday June 11 Morning: 10:00 AM- 11:30 AM
Track 2: MPS for Biomedical Research and Disease Modelling
Theme 2.1: Metabolic disorders and endocrine dysfunction
Find: 422
Abstract: 336
Download now to see how our platform models are designed to support early-stage cardiac drug discovery and toxicity profiling with improved translational relevance.